Technical Analysis for MTEM - Molecular Templates, Inc.

Grade Last Price % Change Price Change
F 0.37 -4.36% -0.02
MTEM closed down 3.89 percent on Wednesday, November 20, 2024, on 7 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
New Uptrend Bullish -4.36%
Calm After Storm Range Contraction -4.36%
Narrow Range Bar Range Contraction -4.36%
Wide Bands Range Expansion -4.36%
Down 3 Days in a Row Weakness -4.36%
Down 4 Days in a Row Weakness -4.36%
Oversold Stochastic Weakness -4.36%
20 DMA Resistance Bearish -8.08%
Calm After Storm Range Contraction -8.08%
Narrow Range Bar Range Contraction -8.08%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 1 hour ago
Down 5% about 1 hour ago
Down 3% about 1 hour ago
Up 3% about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Cancer Treatment Oncology Treatment Of Cancer Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards

Is MTEM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.37
52 Week Low 0.295
Average Volume 12,401,445
200-Day Moving Average 1.62
50-Day Moving Average 0.87
20-Day Moving Average 0.45
10-Day Moving Average 0.41
Average True Range 0.13
RSI (14) 39.39
ADX 25.53
+DI 45.94
-DI 20.41
Chandelier Exit (Long, 3 ATRs) 0.73
Chandelier Exit (Short, 3 ATRs) 0.72
Upper Bollinger Bands 0.61
Lower Bollinger Band 0.28
Percent B (%b) 0.33
BandWidth 75.80
MACD Line -0.12
MACD Signal Line -0.15
MACD Histogram 0.0304
Fundamentals Value
Market Cap 2.09 Million
Num Shares 5.37 Million
EPS -6.92
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.36
Price-to-Book 2.77
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.45
Resistance 3 (R3) 0.45 0.44 0.44
Resistance 2 (R2) 0.44 0.42 0.43 0.43
Resistance 1 (R1) 0.41 0.41 0.40 0.41 0.43
Pivot Point 0.40 0.40 0.39 0.39 0.40
Support 1 (S1) 0.37 0.38 0.37 0.37 0.35
Support 2 (S2) 0.36 0.37 0.36 0.34
Support 3 (S3) 0.33 0.36 0.34
Support 4 (S4) 0.33